TYVYT
LIVE

Serial Number

79253564

Owner

ELI LILLY AND COMPANY

Filing Date

Jan 3, 2019

Add to watchlist:

No watchlists yet
View on USPTO

TYVYT Trademark

Serial Number: 79253564 • Registration: 5934673

TYVYT is a trademark filed by ELI LILLY AND COMPANY on January 3, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

ELI LILLY AND COMPANY (3,822 trademarks)

Entity Type: 03

Innovent Biologics (Suzhou) Co., Ltd. (14 trademarks)

No. 168, Dongping Street
Suzhou City, Jiangsu Province , CN

Entity Type: 99

Trademark Details

Filing Date

January 3, 2019

Registration Date

December 17, 2019

Published for Opposition

October 1, 2019

Goods & Services

Medicines for human purposes used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; pharmaceutical preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; vaccines; chemical preparations for medical purposes, namely, preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; biological preparations for medical purposes, namely, preparations used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases, blood diseases, diabetes, endocrine system diseases, reproductive system diseases, respiratory system diseases, central and peripheral nervous system diseases, and antivirals; pharmaceuticals contained in syringe for treating cancer or tumor; antibiotics; diagnostic preparations for medical purposes; dietetic foods adapted for medical use

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 17, 2024 REM3
CHANGE OF OWNER RECEIVED FROM IB
Jul 30, 2021 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 17, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 28, 2020 FICS
FINAL DISPOSITION PROCESSED
Mar 28, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 17, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 17, 2019 R.PR
NOTIFICATION PROCESSED BY IB
Oct 5, 2019 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 1, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 1, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sep 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 11, 2019 NONP
ASSIGNED TO LIE
Aug 29, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 23, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 17, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 16, 2019 TROA
REFUSAL PROCESSED BY IB
Apr 26, 2019 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 3, 2019 RFCS
REFUSAL PROCESSED BY MPU
Apr 3, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 22, 2019 RFCR
NON-FINAL ACTION WRITTEN
Mar 21, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 15, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 11, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 7, 2019 REPR